Your browser doesn't support javascript.
loading
Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement.
Reyes, Saúl; Cunningham, Anthony L; Kalincik, Tomas; Havrdová, Eva Kubala; Isobe, Noriko; Pakpoor, Julia; Airas, Laura; Bunyan, Reem F; van der Walt, Anneke; Oh, Jiwon; Mathews, Joela; Mateen, Farrah J; Giovannoni, Gavin.
Afiliación
  • Reyes S; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK; Fundación Santa Fe de Bogotá, Bogotá, Colombia; School of Medicine, Universidad de los Andes, Bogotá, Colombia.
  • Cunningham AL; The Westmead Institute, University of Sydney, Sydney, Australia.
  • Kalincik T; CORe, Department of Medicine, University of Melbourne, Melbourne, Australia; Melbourne MS Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia.
  • Havrdová EK; Department of Neurology and Center for Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Isobe N; Department of Neurology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Pakpoor J; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Airas L; Department of Clinical Neurosciences, Turku University Hospital and University of Turku, Turku, Finland.
  • Bunyan RF; Department of Neurology, Neurosciences Center, King Fahd Specialist Hospital (KFSH)-Dammam, Dammam, Saudi Arabia.
  • van der Walt A; Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia.
  • Oh J; Division of Neurology, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.
  • Mathews J; Department of Pharmacy, Royal London Hospital, Barts Health NHS Trust, London, UK.
  • Mateen FJ; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Giovannoni G; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: g.giovannoni@qmul.ac.uk.
J Neuroimmunol ; 357: 577627, 2021 08 15.
Article en En | MEDLINE | ID: mdl-34139567
In this consensus statement, we provide updated recommendations on multiple sclerosis (MS) management during the COVID-19 crisis and the post-pandemic period applicable to neurology services around the world. Statements/recommendations were generated based on available literature and the experience of 13 MS expert panelists using a modified Delphi approach online. The statements/recommendations give advice regarding implementation of telemedicine; use of disease-modifying therapies and management of MS relapses; management of people with MS at highest risk from COVID-19; management of radiological monitoring; use of remote pharmacovigilance; impact on MS research; implications for lowest income settings, and other key issues.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Guías de Práctica Clínica como Asunto / Internacionalidad / COVID-19 / Esclerosis Múltiple Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: J Neuroimmunol Año: 2021 Tipo del documento: Article País de afiliación: Colombia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Guías de Práctica Clínica como Asunto / Internacionalidad / COVID-19 / Esclerosis Múltiple Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: J Neuroimmunol Año: 2021 Tipo del documento: Article País de afiliación: Colombia